RISalud
Institutional Health Repository of Andalucía
Browsing by Author Cobo, Manuel
Showing results 1 to 20 of 42
next >
| Preview | Title | Author(s) | Issue Date |
|---|---|---|---|
| A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3). | Forster, Martin; Hackshaw, Allan; De Pas, Tommaso; Cobo, Manuel; Garrido, Pilar; Summers, Yvonne; Dingemans, Anne-Marie C; Flynn, Michael; Schnell, David; von Wangenheim, Ute; Loembé, Arsene-Bienvenu; Kaiser, Rolf; Lee, Siow Ming | 9-Mar-2018 | |
| A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial. | Peters, Solange; Danson, Sarah; Hasan, Baktiar; Dafni, Urania; Reinmuth, Niels; Majem, Margarita; Tournoy, Kurt G; Mark, Michael T; Pless, Miklos; Cobo, Manuel; Rodriguez-Abreu, Delvys; Falchero, Lionel; Moran, Teresa; Ortega Granados, Ana Laura; Monnet, Isabelle; Mohorcic, Katja; Sureda, Bartomeu Massutí; Betticher, Daniel; Demedts, Ingel; Macias, Jose Antionio; Cuffe, Sinead; Luciani, Andrea; Sanchez, Jose Garcia; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Price, Gillian; Coate, Linda; von Moos, Roger; Zielinski, Christoph; Provencio, Mariano; Menis, Jessica; Ruepp, Barbara; Pochesci, Alessia; Roschitzki-Voser, Heidi; Besse, Benjamin; Rabaglio, Manuela; O'Brien, Mary E R; Stahel, Rolf A | 18-Jun-2020 | |
| A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER. | Goldman, Jonathan W; Mazieres, Julien; Barlesi, Fabrice; Dragnev, Konstantin H; Koczywas, Marianna; Göskel, Tuncay; Cortot, Alexis B; Girard, Nicolas; Wesseler, Claas; Bischoff, Helge; Nadal, Ernest; Park, Keunchil; Lu, Shun; Taus, Alvaro; Cobo, Manuel; Estrem, Shawn T; Wijayawardana, Sameera R; Turner, Kellie; Oakley, Gerard Joseph; Hurt, Karla C; Chiang, Alan Y; Hossain, Anwar M; John, William J; Paz-Ares, Luis | 26-Oct-2020 | |
| ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC). | Morgensztern, Daniel; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E; Lewanski, Conrad R; Bennouna, Jaafar; Fischer, Jürgen R; Juan-Vidal, Oscar; Stewart, David J; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C; Jin Ong, Teng; Govindan, Ramaswamy; On Behalf Of The Abound L Investigators, | 1-Nov-2018 | |
| Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis. | Arriola, Edurne; González-Cao, María; Domine, Manuel; De Castro, Javier; Cobo, Manuel; Bernabé, Reyes; Navarro, Alejandro; Sullivan, Ivana; Trigo, José Manuel; Mosquera, Joaquín; Crama, Leonardo; Isla, Dolores | 15-Jan-2022 | |
| Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial. | Goss, Glenwood D; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Isla, Dolores; Morabito, Alessandro; Min, Young J; Ardizzoni, Andrea; Bender, Shaun; Cseh, Agnieszka; Felip, Enriqueta | 18-Jun-2021 | |
| Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial. | Felip, Enriqueta; Smit, Egbert F; Molina-Vila, Miguel A; Dafni, Urania; Massuti, Bartomeu; Berghmans, Thierry; de Marinis, Filippo; Passiglia, Francesco; Dingemans, Anne-Marie C; Cobo, Manuel; Viteri, Santiago; Britschgi, Christian; Cuffe, Sinead; Provencio, Mariano; Merkelbach-Bruse, Sabine; Andriakopoulou, Charitini; Kammler, Roswitha; Ruepp, Barbara; Roschitzki-Voser, Heidi; Peters, Solange; Wolf, Jürgen; Stahel, Rolf; ETOP 12-17 ALERT-lung Collaborators | 12-Aug-2022 | |
| Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study | Ruano-Ravina, Alberto; Provencio, Mariano; Calvo de Juan, Virginia; Carcereny, Enric; Estival, Anna; Rodríguez-Abreu, Delvys; Benítez, Gretel; López-Castro, Rafael; Belver, Marta; Guirado-Risueño, María; Guirao-Rubio, Carlos; Blasco, Ana; Massutí, Bartomeu; Ortega, Ana Laura; Cobo, Manuel; Mosquera-Martínez, Joaquín; Aguado de la Rosa, Carlos; Bosch-Barrera, Joaquim; Sánchez-Gastaldo, Amparo; Del Barco Morillo, Edel; Juan, Óscar; Dómine, Manuel; Trigo, José Manuel; Pereiro Corbacho, Diego; Oramas, Juana | Oct-2021 | |
| Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma. | Oliver, Javier; Onieva, Juan Luis; Garrido-Barros, Maria; Berciano-Guerrero, Miguel-Ángel; Sánchez-Muñoz, Alfonso; José Lozano, María; Farngren, Angela; Álvarez, Martina; Martínez-Gálvez, Beatriz; Pérez-Ruiz, Elisabeth; Alba, Emilio; Cobo, Manuel; Rueda-Domínguez, Antonio; Barragán, Isabel | 27-Sep-2022 | |
| Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial. | Goss, Glenwood D; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Li, Wei; Guclu, Salih; Isla, Dolores; Min, Young Joo; Morabito, Alessandro; Ardizzoni, Andrea; Gadgeel, Shirish M; Fülöp, Andrea; Bühnemann, Claudia; Gibson, Neil; Krämer, Nicole; Solca, Flavio; Cseh, Agnieszka; Ehrnrooth, Eva; Soria, Jean-Charles | 2018 | |
| Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer. | Karachaliou, Niki; Bracht, Jillian Wilhelmina Paulina; Fernandez Bruno, Manuel; Drozdowskyj, Ana; Gimenez Capitan, Ana; Moran, Teresa; Carcereny, Enric; Cobo, Manuel; Domine, Manuel; Chaib, Imane; Ramirez, Jose Luis; Camps, Carlos; Provencio, Mariano; Vergnenegre, Alain; Lopez-Vivanco, Guillermo; Majem, Margarita; Massuti, Bartomeu; Rosell, Rafael | 22-Nov-2018 | |
| Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial. | Nishio, Makoto; Barlesi, Fabrice; West, Howard; Ball, Simon; Bordoni, Rodolfo; Cobo, Manuel; Longeras, Pascale Dubray; Goldschmidt, Jerome; Novello, Silvia; Orlandi, Francisco; Sanborn, Rachel E; Szalai, Zsuzsanna; Ursol, Grigoriy; Mendus, Diana; Wang, Lijia; Wen, Xiaohui; McCleland, Mark; Hoang, Tien; Phan, See; Socinski, Mark A | 14-Dec-2020 | |
| Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial. | Peters, Solange; Dziadziuszko, Rafal; Morabito, Alessandro; Felip, Enriqueta; Gadgeel, Shirish M; Cheema, Parneet; Cobo, Manuel; Andric, Zoran; Barrios, Carlos H; Yamaguchi, Masafumi; Dansin, Eric; Danchaivijitr, Pongwut; Johnson, Melissa; Novello, Silvia; Mathisen, Michael S; Shagan, Sarah M; Schleifman, Erica; Wang, Jin; Yan, Mark; Mocci, Simonetta; Voong, David; Fabrizio, David A; Shames, David S; Riehl, Todd; Gandara, David R; Mok, Tony | 22-Aug-2022 | |
| CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations. | Felip, Enriqueta; Ardizzoni, Andrea; Ciuleanu, Tudor; Cobo, Manuel; Laktionov, Konstantin; Szilasi, Maria; Califano, Raffaele; Carcereny, Enric; Griffiths, Richard; Paz-Ares, Luis; Duchnowska, Renata; Garcia, Miriam Alonso; Isla, Dolores; Jassem, Jacek; Appel, Wiebke; Milanowski, Janusz; Van Meerbeeck, Jan P; Wolf, Juergen; Li, Ang; Acevedo, Angelic; Popat, Sanjay | 3-Feb-2020 | |
| Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial. | Gridelli, Cesare; Ciuleanu, Tudor; Domine, Manuel; Szczesna, Aleksandra; Bover, Isabel; Cobo, Manuel; Kentepozidis, Nikolaos; Zarogoulidis, Konstantinos; Kalofonos, Charalabos; Kazarnowisz, Andrzej; Korozan, Magdalena; de Las Penas, Ramon; Majem, Margarita; Chella, Antonio; Griesinger, Frank; Bournakis, Evangelos; Sadjadian, Parvis; Kotsakis, Athanasios; Chinet, Thierry; Syrigos, Kostantinos N; Correale, Pierpaolo; Gallou, Catherine; Jamet, Jeanne- Menez; Vetsika, Eleni- Kyriaki; Kosmatopoulos, Kostas; Georgoulias, Vassilis; Vx-001-201 trial team | 25-Mar-2020 | |
| Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: the necessity of repeated molecular analysis | Luis Gonzalez-Larriba, Jose; Lazaro-Quintela, Martin; Cobo, Manuel; Domine, Manuel; Majem, Margarita; Garcia-Campelo, Rosario | 1-Dec-2017 | |
| CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. | Reungwetwattana, Thanyanan; Nakagawa, Kazuhiko; Cho, Byoung Chul; Cobo, Manuel; Cho, Eun Kyung; Bertolini, Alessandro; Bohnet, Sabine; Zhou, Caicun; Lee, Ki Hyeong; Nogami, Naoyuki; Okamoto, Isamu; Leighl, Natasha; Hodge, Rachel; McKeown, Astrid; Brown, Andrew P; Rukazenkov, Yuri; Ramalingam, Suresh S; Vansteenkiste, Johan | 28-Aug-2018 | |
| Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial. | Romero, Atocha; Jantus-Lewintre, Eloisa; García-Peláez, Beatriz; Royuela, Ana; Insa, Amelia; Cruz, Patricia; Collazo, Ana; Pérez Altozano, Javier; Vidal, Oscar Juan; Diz, Pilar; Cobo, Manuel; Hernández, Berta; Vázquez Estevez, Sergio; Benítez, Gretel; Guirado, Maria; Majem, Margarita; Bernabé, Reyes; Ortega, Ana Laura; Blasco, Ana; Bosch-Barrera, Joaquim; Jurado, Jose M; García González, Jorge; Viteri, Santiago; Garcia Giron, Carlos; Massutí, Bartomeu; Lopez Martín, Ana; Rodriguez-Festa, Alejandro; Calabuig-Fariñas, Silvia; Molina-Vila, Miguel Ángel; Provencio, Mariano | 13-Nov-2020 | |
| Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics. | Provencio, Mariano; Cobo, Manuel; Rodriguez-Abreu, Delvys; Calvo, Virginia; Carcereny, Enric; Cantero, Alexandra; Bernabé, Reyes; Benitez, Gretel; Castro, Rafael López; Massutí, Bartomeu; Del Barco, Edel; García Campelo, Rosario; Guirado, Maria; Camps, Carlos; Ortega, Ana Laura; González Larriba, Jose Luis; Sánchez, Alfredo; Casal, Joaquín; Sala, M Angeles; Juan-Vidal, Oscar; Bosch-Barrera, Joaquim; Oramas, Juana; Dómine, Manuel; Trigo, Jose Manuel; Blanco, Remei; Calzas, Julia; Morilla, Idoia; Padilla, Airam; Pimentao, Joao; Sousa, Pedro A; Torrente, Maria | 5-Jul-2022 | |
| Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial. | Rizvi, Naiyer A; Cho, Byoung Chul; Reinmuth, Niels; Lee, Ki Hyeong; Luft, Alexander; Ahn, Myung-Ju; van den Heuvel, Michel M; Cobo, Manuel; Vicente, David; Smolin, Alexey; Moiseyenko, Vladimir; Antonia, Scott J; Le Moulec, Sylvestre; Robinet, Gilles; Natale, Ronald; Schneider, Jeffrey; Shepherd, Frances A; Geater, Sarayut Lucien; Garon, Edward B; Kim, Edward S; Goldberg, Sarah B; Nakagawa, Kazuhiko; Raja, Rajiv; Higgs, Brandon W; Boothman, Anne-Marie; Zhao, Luping; Scheuring, Urban; Stockman, Paul K; Chand, Vikram K; Peters, Solange; MYSTIC Investigators | 2020 |